stemonamine: isolated from Stemona japonica; structure in first source
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Stemona | genus | A plant genus of the family Stemonaceae. Members contain STILBENES and phenyl BENZOFURANS.[MeSH] | Stemonaceae | A small plant family of the order Liliales, subclass Liliidae, class Liliopsida (monocotyledons).[MeSH] |
ID Source | ID |
---|---|
PubMed CID | 181709 |
MeSH ID | M0523595 |
Synonym |
---|
isostemonamine |
stemonamine |
spiro(1h-cyclopenta(b)pyrrolo(1,2-a)azepine-11(10h),2'(5'h)-furan)-5',10-dione, 2,3,5,6,7,8-hexahydro-3'-methoxy-4',9-dimethyl-, (2'r*,11ar*)- |
41758-66-1 |
spiro(1h-cyclopenta(b)pyrrolo(1,2-a)azepine-11(10h),2'(5'h)-furan)-5',10-dione, 2,3,5,6,7,8-hexahydro-3'-methoxy-4',9-dimethyl-, (2'r,11ar)-rel- |
41758-67-2 |
spiro(1h-cyclopenta(b)pyrrolo(1,2-a)azepine-11(10h),2'(5'h)-furan)-5',10-dione, 2,3,5,6,7,8-hexahydro-3'-methoxy-4',9-dimethyl-, (2'r,11as)-rel- |
spiro(1h-cyclopenta(b)pyrrolo(1,2-a)azepine-11(10h),2'(5'h)-furan)-5',10-dione, 2,3,5,6,7,8-hexahydro-3'-methoxy-4',9-dimethyl-, (2'r*,11as*)- |
DTXSID90961959 |
3'-methoxy-4',9-dimethyl-2,3,5,6,7,8-hexahydro-1h,5'h,10h-spiro[cyclopenta[b]pyrrolo[1,2-a]azepine-11,2'-furan]-5',10-dione |
4'-methoxy-3',11-dimethylspiro[5-azatricyclo[8.3.0.01,5]tridec-10-ene-13,5'-furan]-2',12-dione |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.84) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |